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Participants 
All participating countries for each site (Paris, Vancouver, Leiden and London) obtained local 
ethics approval for this study and all participants provided written informed consent.  Sites each 
recruited about 30 controls, 30 premanifest HD (PreHD) and 30 early HD participants. 349 
participants participated in this study, including controls (n=116), premanifest (n=117) and early HD 
(n=116); participants with only baseline data being excluded.  Of the 17 participants excluded, 16 
withdrew prior to the 12-month visit and 1 control had been diagnosed with Parkinson’s disease 
after the baseline visit. Premanifest and early HD participants were required to have had prior 
voluntary independent genetic testing for the HD-CAG repeat expansion.  Repeat CAG testing was 
performed for the study using a polymerase-chain-reaction method.[1]  The PreHD and early HD 
participants had ≥36 and controls had <36 CAG repeats. At the 24 month follow up, of 111 
premanifest participants assessed at 24 months, 78 remained premanifest, 21 were peri-manifest 
(i.e., TMS > 5), and 12 were diagnosed with early HD.   
 
Procedures and Cognitive Assessment  
Cognitive examiners, typically only one individual per site across all three visits, were trained 
and certified in standardised procedures by the first author.  Quality control procedures included 
onsite and online data monitoring and automatic range checks within the database.  As detailed 
previously,[2] participants also underwent MRI, neuropsychiatric, oculomotor, quantitative motor 
and quality of life assessments. 
The test selection was based on findings from the Predict-HD study,[3-5] which included a 
large cognitive battery and focused on PreHD, and on findings from an extensive systematic review 
and meta-analysis of the literature on cognition in PreHD and early HD conducted by our research 
group.  Participants were tested in the language spoken locally at each site.  To minimise the effects 
of using samples being tested in different languages, we selected tests that did not have a large 
verbal component and all instructions and verbal test stimuli were checked by at least two native 
speakers.  Cognitive functions assessed included psychomotor processing speed, visuomotor 
integration, motor speed, planning and correction, visual working memory, odour recognition and 
recognition of facial expressions of emotion.  Computerised testing was completed on identical 
tablet PCs (Lenovo ThinkPad, IBM, New York) using stylus and mouse input devices; the mouse was 
fixed in place on a wooden platform in order to reduce participant fatigue and improve ergonomics.   
Since tests were administered across different countries, all instructions for French- and Dutch-
language administrations went through an extensive local translation process from the original 
English instructions.  Brief descriptions of the tests are as follows: 
i) The Symbol Digit Modalities Test (SDMT)[6] is a paper-and-pencil test of psychomotor speed and 
working memory.  Participants view a ‘key’ at the top of the page containing symbols paired with 
numbers.  The remainder of the page displays rows of symbols and the participant has 90 
seconds to write the corresponding number that matches each symbol. 
ii) Processing speed was assessed using the Stroop Test Word Reading condition, which is a subset 
of the Stroop Colour Word Interference Test.[7] Participants had 45 seconds to read aloud the 
words red, blue and green, printed in a series of rows. 
iii) Visual attention and task switching were assessed using the Trail Making test,[8] which consists 
of 25 circles on a standard sheet of paper.  For Trails A, participants were required to connect, as 
quickly as possible, circles containing numbers in ascending numerical order.  For Trails B, 
participants were to connect, as quickly as possible, circles containing numbers and letters, 
alternating between numbers and letters in ascending order (e.g., 1, A, 2, B, 3, C, etc.). 
iv) To assess visuomotor integration and motor planning, we used the Circle-Tracing task.[9, 10]  
Participants viewed a white annulus, 5 mm thick, against a grey background (i.e., a white circle 
with outer diameter 92.5 mm and inner diameter 87.5 mm).  In each of two conditions, the 
participant traced the annulus by moving a stylus in a circular motion on the tablet screen. In the 
direct condition, the participant could directly view progress on the tablet. In the indirect 
condition, the participant’s tracing arm and the tablet were hidden from view by a drape and 
progress was displayed on an ancillary screen.[10]  Each condition consisted of three trials of 45-
seconds each, and the order of conditions administered was counterbalanced across 
participants. 
v) Emotion recognition of facial expressions of emotions was examined using computerised 
presentations of photographs[11] depicting six basic emotions or a neutral expression as in 
Johnson et al.[12]  Participants were asked to indicate the emotion expressed in each 
photograph by selecting from the words fear, disgust, happy, sad, surprise, angry and neutral (10 
stimuli per emotion).  
vi) Psychomotor function was assessed in a Paced Tapping test using a fast and a slow condition as 
in Stout et al.,[5] and Tabrizi et al.,.[2]  Participants tapped on left and right mouse buttons, 
alternating between thumbs, at 1.8 Hz (slow condition) or 3.0 Hz (fast condition).  They first 
listened to a tone presented at the desired tapping rate, and then began tapping to the tone.  
After 11 taps with the tone, the repetition of the tone was discontinued, and participants 
attempted to continue tapping at the same rate until the end of the trial (31 taps later).  Four 
trials of 1.8 Hz tapping and four trials of 3 Hz tapping were completed, and whether the fast 
trials or the slow trials were administered first was randomised across participants.   
vii) The Serials 2’s Speeded Tapping task required participants to tap, as quickly as possible, for 10 
seconds with their non-dominant index finger on a computer mouse button, whilst counting 
backwards aloud by 2’s.  The task consisted of 5 trials with each trial commencing with a 
different number (99, 98, 97, 96 and 95) to minimize practice effects.  
viii) Visual working memory was assessed using the Spot the Change task that was developed by our 
group based on Cowan et al.[13]  An array of coloured squares was presented for 250 ms, and, 
after a 1000 ms pause, a similar array was presented with one of the squares encircled. 
Participants were given 8000 ms to decide whether the encircled square had changed colour as 
compared to the same positioned square in the first array by responding ‘same’ (dominant 
thumb) or ‘different’ (non-dominant thumb) on the mouse buttons.  A set size of 5 (i.e., number 
of squares presented on the screen) was used over the three data collection visits. Set size 3 was 
omitted after the first visit due to ceiling effects, and set size 7 was only introduced at the 
second visit.  The design therefore provided longitudinal (i.e., 12- and 24-month) data for set size 
5 only, which also presented the most symmetric distribution.  The set size 5 portion of the task 
consisted of 32 trials. 
ix) Odour recognition was assessed with a 20-item version of the University of Pennsylvania Smell 
Identification Test (UPSIT; Sensonics, Inc., Haddon Heights, NJ)[14].  Participants were required 
to ‘scratch and sniff’ 20 odour-patches and to identify the correct odour from a multiple-choice 
response set.  
 
Statistical analysis 
We used the standard deviation of change in the disease group (rather than pooling this 
with the standard deviation in controls) so that the effect sizes can be used to calculate necessary 
sample sizes for future clinical trials. In such sample size calculations it is commonly assumed that 
treatments will potentially alter mean rates of change without altering variability.  Therefore, the 
standard deviations in HD cases are the ones of primary interest.   
Considerations for the statistical model:  Change in performance typically depends on the 
length of time between measures, and we have assumed that disease-related changes are linear 
over a 24 month period.  Because cognitive tests are subject to improvements due to practice, and 
these improvements are largest from the first exposure to the second exposure, we expected 
practice-related change in cognitive measures to be larger over the first year than over the second 
year.  Thus, in our statistical models, we included both time from baseline, and an indicator variable 
that allowed the change between baseline and 12 months to differ from that between 12 and 24 
months (over and above any effect of time interval).  Because we wanted to allow the linear effect 
of time, differential practice effects, and average performance over all three time periods, to vary 
according to HD status (control, premanifest HD or early HD), we fitted GLS models with group 
specific intercepts, group specific slopes and group specific practice effect indicators.  All analyses 
additionally controlled for age, sex, educational level and study site, as well as their interactions with 
time and practice effects.  GLS models were selected because they allow for correlations in 
measurements from the same participant.  Because we did not wish to constrain the residual 
variances for different visits or the covariances between pairs of visits in any way, we specified an 
unstructured covariance matrix, also allowing residual variances and covariances to differ according 
to HD group.   
References 
 
1. Warner JP, Barron LH, Brock DJH. A new polymerase chain-reaction (PCR) assay for the 
trinucleotide repeat that is unstable and expanded on Huntingtons-disease chromosomes. 
Mol Cell Probes 1993;7:235-9. 
2. Tabrizi SJ, Langbehn DR, Leavitt BR, et al. Biological and clinical manifestations of 
Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline 
data. Lancet Neurol 2009;8:791-801. 
3. Paulsen JS, Hayden MR, Stout JC, et al. Preparing for preventive clinical trials: The Predict-HD 
study. Arch Neurol 2006;63:883-90. 
4. Paulsen JS, Langbehn DR, Stout JC, et al. Detection of Huntington's disease decades before 
diagnosis: The Predict-HD study. J Neurol Neurosurg Psychiatry 2008;79:874-80. 
5. Stout JC, Paulsen J, Queller S, et al. Neurocognitive signs in prodromal Huntington disease. 
Neuropsychology 2011;25:1-14. 
6. Smith A. Symbol Digits Modalities Test. Los Angeles: Western Psychological Services; 1991. 
7. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol Gen 1935;18:643-
62. 
8. Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. Percept 
Mot Skills 1958;8:271-6. 
9. Lemay M, Fimbel E, Beuter A, Chouinard S, Richer F. Sensorimotor mapping affects 
movement correction defiticts in early Huntington's disease. Exp Brain Res 2005;165:454-60. 
10. Say MJ, Jones R, Scahill RI, et al. Visuomotor integration deficits preced clinical onset in 
Huntington's disease. Neuropsychologia 2011;49:264-70. 
11. Ekman P, Friesen WV. Measuring facial movement. Environmental Psychology and Nonverbal 
Behavior 1976;1:56-75. 
12. Johnson SA, Stout JC, Solomon AC, et al. Beyond disgust: Impaired recognition of negative 
emotions prior to diagnosis in Huntington's disease. Brain 2007;130:1732-44. 
13. Cowan N, Elliott EM, Saults JS, et al. On the capacity of attention: Its estimation and its role 
in working memory and cognitive aptitudes. Cogn Psychol 2005;51:42-100. 
14. Doty RL, Shaman P, Kimmelman CP, Dann MS. University of Pennsylvania Smell Identification 
Test: A rapid quantitative olfactory function test for the clinic. Laryngoscope 1984;94:176-8. 
 
 
 
